CD31 Antibody Market was valued at USD 0.45 Billion in 2022 and is projected to reach USD 0.68 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030.
The CD31 antibody market was valued at approximately USD 300 million in 2022, with a robust growth trajectory. The market is projected to expand at a compound annual growth rate (CAGR) of 6.5% from 2023 to 2028. This growth is driven by increasing applications in cancer research, immunology, and vascular biology. The rising prevalence of cancer and other chronic diseases, alongside advancements in research and development, are key factors contributing to the market's expansion. The demand for CD31 antibodies is particularly high in the field of oncology for the identification and characterization of endothelial cells and in developing targeted therapies. Emerging markets in Asia-Pacific and Latin America are expected to offer significant opportunities for growth. These regions are experiencing rapid advancements in healthcare infrastructure and research capabilities, driving the demand for specialized antibodies like CD31. Furthermore, increased investment in biotechnology and pharmaceutical industries in these regions is anticipated to enhance market potential. The shift towards personalized medicine and the growing focus on research into immune system-related diseases are likely to bolster market growth and open up new avenues for investment and development in the CD31 antibody sector.
Get an In-Depth Research Analysis of the Global CD31 Antibody Market Size And Forecast [2025-2032]
BosterBio
Bio-Rad
Bioss
Thermo Fisher Scientific
NSJ Bioreagents
R and D Systems
Abcam
BioLegend
GeneTex
Novus Biologicals
SouthernBiotech
LifeSpan BioSciences
Enzo Life Sciences
Bethyl Laboratories
Abbexa
ProSci
Proteintech
Synaptic Systems
BIOCARE MEDICAL
CUSABIO Technology
Absolute Antibody
EpiGentek
Biorbyt
Wuhan Fine Biotech
Sino Biological
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global CD31 Antibody Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global CD31 Antibody Market
Immunochemistry (IHC)
Immunofluorescence (IF)
Western Blot (WB)
Immunocytochemistry (ICC)
ELISA
Others
Based on Types the Market is categorized into Below types that held the largest CD31 Antibody market share In 2023.
Monoclonal
Polyclonal
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ CD31 Antibody Market Research Analysis
1. Introduction of the Global CD31 Antibody Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global CD31 Antibody Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global CD31 Antibody Market, By Type
6. Global CD31 Antibody Market, By Application
7. Global CD31 Antibody Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global CD31 Antibody Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/